ArticleCancer immunology, immunotherapy : CII2007

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.

Arthur Machlenkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.